German company BioNTech and its US partner Pfizer announced on Monday that early results from ongoing Phase III trials showed that their vaccine was 90% effective in preventing COVID-19 infections.
The statement from the two companies is the first release of successful data from a large-scale trial of coronavirus vaccines.
According to their reports, they found no serious safety concerns connected with the vaccine. Researchers believe the immunizing effects will not be short-lived.
If substantiated, the Pfizer and BioNTech vaccine would be a breakthrough in the fight against the coronavirus pandemic.
Effects could last ‘at least a year’
BioNTech’s CEO Ugur Sahin told Reuters that: “We should be more optimistic that the immunization effect can last for at least a year.”
“The first set of results from our Phase III COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” Pfizer Chairman and CEO Albert Bourla said in a statement.
Analysis of the experimental vaccine trials appeared to effectively prevent infection in participants “without prior evidence of SARS-CoV-2 infection,” the joint statement said.
Pfizer cautioned that the initial protection rate may still change as time goes on and made clear that the vaccine was unlikely to be available before the end of the year. Nevertheless, Pfizer’s senior vice president of clinical development, Dr. Bill Gruber told the Associated Press: “We are very encouraged.”
Biden and Trump welcome vaccine news
US President-elect Joe Biden welcomed the promising results from the vaccine trials, but warned that widespread vaccination was still months away. He also urged the US public to continue wearing masks and social distancing.
“Today’s news is great news, but it doesn’t change that fact,” Biden said in a statement. “Today’s announcement promises the chance to change that next year, but the tasks before us now remain the same.”
US President Donald Trump, celebrated the news and the boost to the stock market as “SUCH GREAT NEWS,” in a post on Twitter.
European stock markets reacted positively to the news with Pfizer’s share increasing 6% while BioNTech’s US stocks rocketed up by 18%.
more recommended stories
Vila supervises the new units of the “Va y Ven” Periférico public transport route
This new transport route covers the.
Women’s softball, the sport of excellence among the Yucatán rural communities
YUCATAN, (September 21, 2021).- Softball has.
Cablebus Line 2 failure in Iztapalapa and left several users ‘suspended in the air’
MEXICO CITY, (September 21, 2021).- Users.
Justin Trudeau wins Canada vote but fails to get majority
Prime Minister Justin Trudeau’s Liberal Party.
Compact car burns down in Mérida’s Garcia Gineres neighborhood
Mérida, Yucatán, (September 21, 2021) .-.
Doctor commits suicide at his home in Mérida´s Aleman Avenue
MÉRIDA, Yucatán, (September 21, 2021).- Agents.
Foreign Minister Marcelo Ebrard assured that Mexico is willing to welcome Haitian migrants
MEXICO, (September 21, 2021).- The Government.
Pandemic slows down real estate ‘boom’ in Downtown Mérida
The properties of the Historic Center.
Autumn equinox at Chichén Itzá will take place without visitors this year
Due to pandemic, the site will.
Vila Dosal says the relocation of the airport will improve the quality of life in southern Merida
Merida, Yucatan, (September 21, 2021).- Given.